TCA
MEDP icon

Transcend Capital Advisors’s Medpace MEDP Stock Holding History

Transcend Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Sell
886
-21
-2% -$9.69K 0.03% 479
2026
Q1 		$436K Sell
907
-375
-29% -$192K 0.03% 415
2025
Q4 		$720K Buy
1,282
+335
+35% +$190K 0.06% 300
2025
Q3 		$487K Buy
+947
New +$413K 0.03% 377

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Transcend Capital Advisors's MEDP Position: Q2 2026 in Review

Transcend Capital Advisors reduced its Medpace (MEDP) stake by 2.3% in Q2 2026, selling an estimated $9.69K and leaving 886 shares worth $469K. The position accounts for 0.03% of the portfolio, ranked #479.

Transcend Capital Advisors first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $720K in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Transcend Capital Advisors held 886 shares of Medpace worth $469K as of Q2 2026.
  • Transcend Capital Advisors sold 21 Medpace shares in Q2 2026, an estimated $9.69K.
  • Medpace made up 0.03% of Transcend Capital Advisors's portfolio in Q2 2026, its #479 holding.
  • Transcend Capital Advisors first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Transcend Capital Advisors's Medpace position peaked at $720K in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.